Skip to main content
OpenTrials

Clinical trial condition

Astrocytoma

Explore clinical trials studying Astrocytoma. Study availability and eligibility vary by location and protocol.

497 public trials 63 recruiting studies
Refine in advanced search Browse all conditions

Astrocytoma trial results

Recruiting

Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

NCT06860594

Conditions
Astrocytoma, Astrocytoma, IDH-Mutant, Grade 2, Glioblastoma, +22 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
View all 43 locations
View Trial Details
Recruiting

Vorasidenib Maintenance for IDH Mutant Astrocytoma

NCT06809322

Conditions
Astrocytoma, Glioma, IDH-mutant Grade 2 or 3 Astrocytoma, +7 more
Locations
  • Medical University of Innsbruck Innsbruck, Austria
  • Kepler University Hospital - Neuromed campus Linz, Austria
  • Medical University of Vienna Vienna, Austria
  • Universitair Ziekenhuis Brussel Brussels, Belgium
View all 33 locations
View Trial Details
Recruiting

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

NCT05417594

Conditions
Adnexal Diseases, Advanced Solid Malignancies, Astrocytoma, +36 more
Locations
  • Research Site La Jolla, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site San Francisco, California, United States
  • Research Site Chicago, Illinois, United States
View all 32 locations
View Trial Details
Recruiting

Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer

NCT07215910

Conditions
Astrocytoma, Astrocytoma, IDH-Mutant, Grade 3, Glioma, +15 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
View all 97 locations
View Trial Details
Recruiting

A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma

NCT05765812

Conditions
Astrocytoma, Astrocytoma, Grade III, Glioblastoma, +17 more
Locations
  • Northwestern Memorial Hospital Chicago, Illinois, United States
  • New York University Langone Medical Center New York, United States
  • David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center New York, United States
  • Baylor Scott & White Research Institute Dallas, Texas, United States
View all 16 locations
View Trial Details

Related conditions